AllianceBernstein’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Hold |
67,900
| – | – | ﹤0.01% | 1610 |
|
|
2025
Q1 | $3.28M | Sell |
67,900
-325
| -0.5% | -$15.7K | ﹤0.01% | 1639 |
|
|
2024
Q4 | $2.63M | Sell |
68,225
-13,694
| -17% | -$529K | ﹤0.01% | 1821 |
|
|
2024
Q3 | $3.69M | Sell |
81,919
-13,250
| -14% | -$596K | ﹤0.01% | 1661 |
|
|
2024
Q2 | $3.3M | Buy |
95,169
+9,769
| +11% | +$338K | ﹤0.01% | 1681 |
|
|
2024
Q1 | $2.47M | Hold |
85,400
| – | – | ﹤0.01% | 1806 |
|
|
2023
Q4 | $1.96M | Sell |
85,400
-1,872
| -2% | -$42.9K | ﹤0.01% | 1950 |
|
|
2023
Q3 | $1.46M | Buy |
87,272
+7,072
| +9% | +$118K | ﹤0.01% | 2044 |
|
|
2023
Q2 | $2.22M | Buy |
80,200
+26,000
| +48% | +$718K | ﹤0.01% | 1842 |
|
|
2023
Q1 | $1.25M | Hold |
54,200
| – | – | ﹤0.01% | 2118 |
|
|
2022
Q4 | $591K | Buy |
54,200
+14,200
| +36% | +$155K | ﹤0.01% | 2538 |
|
|
2022
Q3 | $337K | Sell |
40,000
-6,000
| -13% | -$50.6K | ﹤0.01% | 2811 |
|
|
2022
Q2 | $364K | Sell |
46,000
-80,463
| -64% | -$637K | ﹤0.01% | 2815 |
|
|
2022
Q1 | $3M | Buy |
126,463
+80,563
| +176% | +$1.91M | ﹤0.01% | 1841 |
|
|
2021
Q4 | $1.57M | Hold |
45,900
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q3 | $813K | Hold |
45,900
| – | – | ﹤0.01% | 2568 |
|
|
2021
Q2 | $2.06M | Buy |
45,900
+15,300
| +50% | +$687K | ﹤0.01% | 2161 |
|
|
2021
Q1 | $793K | Buy |
30,600
+2,600
| +9% | +$67.4K | ﹤0.01% | 2481 |
|
|
2020
Q4 | $564K | Hold |
28,000
| – | – | ﹤0.01% | 2533 |
|
|
2020
Q3 | $547K | Hold |
28,000
| – | – | ﹤0.01% | 2476 |
|
|
2020
Q2 | $494K | Buy |
28,000
+11,900
| +74% | +$210K | ﹤0.01% | 2612 |
|
|
2020
Q1 | $114K | Buy |
16,100
+3,500
| +28% | +$24.8K | ﹤0.01% | 2920 |
|
|
2019
Q4 | $89K | Hold |
12,600
| – | – | ﹤0.01% | 3044 |
|
|
2019
Q3 | $151K | Buy |
+12,600
| New | +$151K | ﹤0.01% | 2997 |
|